Jinyu Bio-Technology Co

Jinyu Bio-Technology Co EBITDA Margin

The EBITDA Margin of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 8.58 %. In the previous year, EBITDA Margin was 16.59 % — a change of -48.32% (lower).

EBITDA Margin

8.58 %

YoY

-48.32%

Last updated:

EBITDA Margin of Jinyu Bio-Technology Co is 2025 8.58 % . EBITDA Margin of Jinyu Bio-Technology Co was 2024 16.59 % . It decreases by -48.32% lower compared to the previous year.

The Jinyu Bio-Technology Co EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2018
48.97 CNY
Jan 1, 2019
27.26 CNY
Jan 1, 2020
35.47 CNY
Jan 1, 2021
28.70 CNY
Jan 1, 2022
21.82 CNY
Jan 1, 2023
23.30 CNY
Jan 1, 2024
16.59 CNY
Jan 1, 2025
8.58 CNY
The Jinyu Bio-Technology Co EBITDA Margin history
YEAREBITDA MarginYoY
8.58 %-48.32%
16.59 %-28.78%
23.30 %+6.76%
21.82 %-23.97%
28.70 %-19.10%
35.47 %+30.15%
27.26 %-44.34%
48.97 %-9.80%
54.29 %+5.67%
51.37 %+5.86%
48.53 %+5.55%
45.98 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

EBITDA Margin of Jinyu Bio-Technology Co is 8.58 % in 2025.

EBITDA Margin of Jinyu Bio-Technology Co changed from 16.59 % to 8.58 %, representing a -48.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Jinyu Bio-Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Jinyu Bio-Technology Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Jinyu Bio-Technology Co